Early Human Test for Connexus Implant
Paradromics, a Texas-based brain-computer interface (BCI) startup, has just achieved a noteworthy milestone. The company reported that it successfully implanted its device, Connexus, in a human patient. The procedure lasted around 10 minutes, after which the implant was safely removed. The brief trial was a safety evaluation, aiming to pave the way for longer, more complex clinical studies. This marks the first time Paradromics has tested Connexus in a human subject, signifying growing momentum in neurotechnology beyond the more publicized efforts of Neuralink.
Competing in the Brain-Computer Arena
What sets Paradromics apart? The company's Connexus device features an array of tiny electrodes that can record and stimulate neural activity. Its goal is to provide a direct communication link between the brain and computers, which could someday restore speech or movement for people with neurological disorders.
- Paradromics' approach includes high-resolution neural interfaces using hundreds of microelectrodes.
- The company also aims for a design that's less invasive than traditional BCI surgeries.
Friday, 06 June 2025
Friday, 06 June 2025 - 106 views